drugset
drugset / Trial / NCT01933685

Study of Immune Responses Induced by a HIV Vaccine

NCT01933685 ↗

Phase 2 Unknown 40 enrolled U.S. Army Medical Research and Development Command National Institutes of Health (NIH) · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to define the immune responses induced by a HIV vaccine, AIDSVAX B/E. Blood and mucosal samples will be collected to assess immune responses.

Timeline

Start
2014-07-03
Primary completion
2016-05-24
Completion
2020-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AIDSVAX B/E Vaccine 600 ug Other

Indications

HIV infectious disease